BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 11905710)

  • 1. Current and future developments in the use of temozolomide for the treatment of brain tumours.
    Stupp R; Gander M; Leyvraz S; Newlands E
    Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of temozolomide in recurrent malignant gliomas.
    Gaya A; Rees J; Greenstein A; Stebbing J
    Cancer Treat Rev; 2002 Apr; 28(2):115-20. PubMed ID: 12297119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide in malignant gliomas: current use and future targets.
    Villano JL; Seery TE; Bressler LR
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.
    Charnley N; West CM; Barnett CM; Brock C; Bydder GM; Glaser M; Newlands ES; Swindell R; Matthews J; Price P
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):331-8. PubMed ID: 16839701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rechallenge with temozolomide in recurrent glioma.
    Gaviani P; Silvani A; Lamperti E; Botturi A; Fariselli L; Simonetti G; Ferrari D; Salmaggi A
    Neurol Sci; 2011 Nov; 32 Suppl 2():S247-9. PubMed ID: 21987286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma.
    Schönekaes K; Mücke R; Panke J; Rama B; Wagner W
    Tumori; 2002; 88(1):28-31. PubMed ID: 12004846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal role of temozolomide in the treatment of malignant gliomas.
    Stupp R; van den Bent MJ; Hegi ME
    Curr Neurol Neurosci Rep; 2005 May; 5(3):198-206. PubMed ID: 15865885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
    Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
    Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches for temozolomide therapy: use in newly diagnosed glioma.
    Stupp R; Newlands E
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):19-23. PubMed ID: 11550135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide: a novel oral alkylating agent.
    Danson SJ; Middleton MR
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):13-9. PubMed ID: 12113120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
    Kyritsis AP; Levin VA
    Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide: a milestone in neuro-oncology and beyond?
    Mutter N; Stupp R
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1187-204. PubMed ID: 16925485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current evidence of temozolomide and bevacizumab in treatment of gliomas.
    Nanegrungsunk D; Onchan W; Chattipakorn N; Chattipakorn SC
    Neurol Res; 2015 Feb; 37(2):167-83. PubMed ID: 25033940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide: Expanding its role in brain cancer.
    Mrugala MM; Adair J; Kiem HP
    Drugs Today (Barc); 2010 Nov; 46(11):833-46. PubMed ID: 21225022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant radiotherapy and metronomic temozolomide in pediatric high-risk brain tumors.
    Sterba J; Pavelka Z; Slampa P
    Neoplasma; 2002; 49(2):117-20. PubMed ID: 12088104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide and treatment of malignant glioma.
    Friedman HS; Kerby T; Calvert H
    Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of temozolomide in malignant brain tumours.
    Osoba D
    Lancet; 2000 Jul; 356(9226):342. PubMed ID: 11071219
    [No Abstract]   [Full Text] [Related]  

  • 20. [Favourable result for temozolomide in recurrent high-grade glioma].
    Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.